Menta Capital’s Nektar Therapeutics NKTR Stock Holding History

Menta Capital’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,227	Closed	-$432K	–	868
2017 Q1	$432K	Buy	+1,227	New	+$276K	0.04%	605
2015 Q3	–	Sell	-9,587	Closed	-$1.8M	–	781
2015 Q2	$1.8M	Buy	+9,587	New	+$1.65M	0.29%	88
2015 Q1	–	Sell	-10,747	Closed	-$2.5M	–	770
2014 Q4	$2.5M	Buy	+10,747	New	+$2.3M	0.35%	78

Other funds holding NKTR

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Menta Capital's NKTR Position: Q2 2017 in Review

Menta Capital sold out of Nektar Therapeutics (NKTR) in Q2 2017, closing a stake of 1,227 shares — an estimated $432K sold.

Menta Capital first reported a position in NKTR in Q4 2014 and held it in 3 quarters. The position peaked at $2.5M in Q4 2014. 197 funds tracked by Wall St. Rank hold NKTR as of Q2 2017.

Menta Capital reported no remaining Nektar Therapeutics position as of Q2 2017 after selling out during the quarter.
Menta Capital sold 1,227 Nektar Therapeutics shares in Q2 2017, an estimated $432K.
Menta Capital first reported a position in Nektar Therapeutics in Q4 2014 and held it in 3 quarters.
Menta Capital's Nektar Therapeutics position peaked at $2.5M in Q4 2014.
197 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2017.

Based on Menta Capital's 13F filing for Q2 2017, filed 11 Aug 2017.